SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-19-001436
Filing Date
2019-02-13
Accepted
2019-02-13 12:50:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT gtbp_424b3.htm 424B3 608110
2 IMAGE gtbp_424b3000.jpg GRAPHIC 4167
3 IMAGE gtbp_424b3001.jpg GRAPHIC 5413
  Complete submission text file 0001654954-19-001436.txt   622893
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-223349 | Film No.: 19595568
SIC: 2834 Pharmaceutical Preparations